Actively Recruiting
Montelukast in Parkinson Disease
Led by Mostafa Bahaa · Updated on 2026-03-13
60
Participants Needed
1
Research Sites
163 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease (AD). Clinical manifestations of PD can vary, but a formal diagnosis relies on the presence of bradykinesia with rigidity and/or rest tremor according to Movement Disorder Society (MDS) criteria for PD. Non-motor symptoms, such as hyposmia, constipation, depression, and rapid eye movement (REM) sleep behavior disorder, are common and can in many cases manifest before classical motor symptoms. In later years, more emphasis has been put on non-motor symptoms, especially in the early stages of PD and which is evident in the proposed prodromal PD criterion by MDS.
CONDITIONS
Official Title
Montelukast in Parkinson Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 65 18 years
- Both male and female will be included
- Negative pregnancy test and effective contraception
- Diagnosed Parkinson's disease patient taking Levodopa
You will not qualify if you...
- Secondary causes of parkinsonism
- Patients taking anti-inflammatory drugs
- Atypical parkinsonian syndromes
- Prior stereotaxic surgery for Parkinson's disease
- Pregnancy and lactation
- Suffering from active malignancy
- Addiction to alcohol and/or drugs
- Known allergy to the studied medications
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Faculty of Medicine, Mansoura University
Al Mansurah, Egypt, 35511
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here